Related Experiment Video
Updated: Apr 20, 2026
10:11
Expression of Exogenous Antigens in the Mycobacterium bovis BCG Vaccine via Non-genetic Surface Decoration with the Avidin-biotin System
Published on: January 31, 2018
9.9K
TB vaccine development: where are we and why is it so difficult?
Morven E M Wilkie1, Helen McShane1
1The Jenner Institute, University of Oxford, Old Road Campus Research Building, Oxford, UK.
Thorax
|November 30, 2014
Summary
Developing a new tuberculosis (TB) vaccine is crucial for global eradication efforts. This research discusses challenges and future directions for innovative TB vaccines beyond the limited BCG vaccine.
Area of Science:
- * Immunology and vaccinology
- * Infectious disease research
- * Global public health
Background:
- * The current Bacillus Calmette-Guérin (BCG) vaccine for tuberculosis (TB) has inconsistent efficacy, particularly in high-burden regions.
- * Global eradication of TB by 2050 necessitates improved vaccination strategies.
- * There is a critical need for novel TB vaccine candidates.
Purpose of the Study:
- * To review the challenges in developing effective tuberculosis vaccines.
- * To explore strategies for next-generation TB vaccines, including BCG-boost and BCG-replacement candidates.
- * To identify future research directions and hurdles in TB vaccine development.
Main Methods:
- * Literature review and synthesis of current research on TB vaccine development.
- * Analysis of issues encountered with existing and novel vaccine candidates.
- * Discussion of immunological principles relevant to TB vaccine design.
Main Results:
- * Existing TB vaccine development faces significant scientific and logistical challenges.
- * Candidate vaccines aim to either enhance BCG-induced immunity or provide an alternative.
- * Variability in BCG efficacy highlights the need for improved vaccine formulations or novel approaches.
Conclusions:
- * Overcoming current obstacles is essential for advancing TB vaccine development.
- * Innovative research is vital for creating vaccines that can achieve global TB eradication.
- * Future efforts must address the limitations of BCG and explore diverse vaccine platforms.
Keywords:
Tuberculosis
Related Concept Videos
01:23Vaccine Production
110
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
110
01:29Microorganisms in Medicine and Therapeutics
1.5K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.5K
01:51Vaccinations
54.7K
Overview
54.7K
01:21Vaccines
63
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
63
01:22Development of Immunocompetence
1.2K
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.2K
01:30Cancer Vaccines
1.4K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.4K